About
Scribe Therapeutics develops engineered CRISPR-based genetic medicine solutions to enable enhanced gene editing therapies.
Explore Scribe Therapeutics Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.